Fujirebio Begins Testing for Fully Automated SARS-CoV-2 Antigen Assay
Fujirebio Diagnostics has begun the clinical testing of its new SARS-CoV-2 antigen assay with the goal of providing the first fully automated antigen test.
Read MorePosted by Melanie Hamilton-Basich | Aug 6, 2020 | Covid 19, Uncategorized |
Fujirebio Diagnostics has begun the clinical testing of its new SARS-CoV-2 antigen assay with the goal of providing the first fully automated antigen test.
Read MorePosted by Melanie Hamilton-Basich | Aug 6, 2020 | Covid 19 |
These include biochemical profiling for covid-19 drug targets as well as cellular and molecular assays.
Read MorePosted by Melanie Hamilton-Basich | Aug 6, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The covid-19 IgG/IgM rapid test delivers results in about 15 minutes and has shown a high level of accuracy.
Read MorePosted by Melanie Hamilton-Basich | Aug 6, 2020 | Company News, Covid 19 |
The Israeli company behind the first FDA-cleared direct-from-fingerstick CBC analyzer plans to expand its operations in the United States.
Read MorePosted by Melanie Hamilton-Basich | Aug 5, 2020 | Covid 19, Information Technology |
The US-based CPG company used LabVantage Covid-19 LIMS for an in-house covid-19 testing center where employees can quickly and safely be tested.
Read More